Spots Global Cancer Trial Database for Effects of Dexamethasone on Common Bile Duct Cannulation Time

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Effects of Dexamethasone on Common Bile Duct Cannulation Time

Official Title: Can Deep Common Bile Duct Cannulation Time During Endoscopic Retrograde Cholangiopancreatography be Shortened by Dexamethasone

Study ID: NCT05945797

Conditions

Common Bile Duct Diseases

Common Bile Duct Calculi

Common Bile Duct Stricture

Common Bile Duct Neoplasms

Common Bile Duct Dilatation

Interventions

Dexamethasone 4mg

Study Description

Brief Summary: The main aim of this clinical trial is to evaluate the effects of dexamethasone on common bile duct cannulation time during endoscopic retrograde cholangiopancreatography (ERCP) in patients with biliary pathologies. The study will also study the effects of dexamethasone on total procedure time and total fluoroscopy time during ERCP. Participants will be divided into two groups, treatment group and placebo group. Patients in treatment group will receive dexamethasone and those in placebo group will be given normal saline before undergoing ERCP. The results in both groups will be compared to determine the effects of dexamethasone.

Detailed Description: